Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Neshaut Mashreghi Mohammadi
Observed names:
Mohammadi, Neshaut Mashreghi,
Neshaut Mashreghi
Institutions:
Pharmaceutical Management and Economics Research Center,
Tehran University of Medical Sciences
Observed institutions:
Pharmaceutical Quality Assurance Research Center,
Pharmaceutical Management and Economics Research Center,
Tehran University of Medical Sciences
ORCID:
0000-0002-8978-343X
Observed ORCID:
0000-0002-8978-343X
OpenAlex ID:
A5042283660
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
2022
·
Gelareh Abdolmaleki
, Mina Azam Taheri
, et al.
·
DARU Journal of Pharmaceutical Sciences
·
26
PDF
Potential Treponema denticola-based periodontal vaccine to resolve a global public health challenge: a narrative literature review
2022
·
Navid Mirmohammadsadegh
, Neshaut Mashreghi Mohammadi
, et al.
·
Expert Review of Vaccines
·
7
1-Methyl-2-pyrrolidinone
2023
·
Neshaut Mashreghi
, Zahra Bayrami
·
Elsevier eBooks
·
2
Cost-Effectiveness Analysis of Carfilzomib vs Bortezomib in Relapsed/Refractory Multiple Myeloma in Iran
2026
·
Neshaut Mashreghi Mohammadi
, Behzad Fatemi
, et al.
·
Value in Health Regional Issues
Decoding the Applications of Microbial Metabolites: Insights into the Antibacterial Potential of Lactobacillus acidophilus Postbiotics
2026
·
Seyed Sadeq Mousavi Ghahfarrokhi
, Bibi Sedigheh Fazly Bazzaz
, et al.
·
Current Microbiology
Cost-utility analysis of Lenvatinib vs. Sorafenib in unresectable hepatocellular carcinoma in Iran
2025
·
Mohammad Mahdi Raeis Zadeh
, Behzad Fatemi
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
Show more works
View as search
Works count:
7
Citation count:
35
H-index:
2
I10-index:
1
Year
Topic
Type
